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Systemic Inflammation, Atrial Fibrillation,
and Cancer
To the Editor:
The article by Chung et al1 reports a significant elevation of
C-reactive protein (CRP) in patients with atrial fibrillation (AF).
The CRP elevation was found both in patients with lone
arrhythmia and in patients with structural heart disease. More-
over, the higher CRP levels were seen in patients with persistent,
rather than paroxysmal, AF.
We recently conducted a study to quantify the clinical obser-
vation of an unexpectedly high frequency of AF in patients with
colorectal cancer.2 We considered a total of 1463 patients
admitted to our Department of Surgery from 1987 to 1998 for
surgical treatment of colorectal cancer (case group; mean age
66.0 years, 54% males) or nonneoplastic diseases including
inguinal hernia, cholelithiasis, varicose veins, and hemorrhoids
(control group; mean age 65.6 years, 61% males). We found that
atrial fibrillation was three times as likely in patients with first
diagnosis of colorectal cancer compared with controls (Mantel-
Haenszel sex-adjusted odds ratio3.5; Cornfield 95% confi-
dence interval1.6 to 7.2). Logistic analysis was used to exclude
an effect of age. All of the patients studied were at the first stage
of their diagnosis of colorectal cancer, and they had not received
any chemotherapy or previous major surgery.
Different pathophysiological mechanisms could explain our
observations: a clinical or subclinical hyperthyroidism related to
an abnormal release of thyroid-stimulating hormone or T3-like
peptides by the tumor; an imbalance between sympathetic and
parasympathetic cardiac autonomic control; an autoimmune
paraneoplastic syndrome with inflammatory involvement of
atrial structures as antigens.3
Chung et al1 suggest in their article that AF could be promoted
and maintained by atrial structural remodeling because of an
inflammatory state, and that elevated CPR may reflect this
condition. The cause of the inflammatory state remains un-
known.1 Taking into account the results of our study, the
presence of a tumor can sustain systemic inflammation with CPR
elevations and could predispose some patients to the develop-
ment of AF. Moreover, the higher mortality reportedly associated
with AF, even after adjustment for preexisting cardiovascular
conditions,4 could be explained in some of these patients by the
presence of an inflammatory state due to an occult neoplasm or
other systemic inflammatory diseases.
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The letter of Dr Guzzetti and colleagues reports that the
incidence of atrial fibrillation is higher in patients with colorectal
cancer. Neoplastic diseases could certainly provide the basis for
an inflammatory state that could promote atrial fibrillation. Their
study thus offers corroborative evidence linking atrial fibrillation
and inflammation. In our study,1 a history of cancer was reported
in 28/202 patients. Cancer was significantly associated with atrial
arrhythmias (4/71 [5.6%] of patients without and 24/131 [18.3%]
of patients with atrial arrhythmias had history of cancer,
P0.018). Cancer was also significantly associated with eleva-
tion of C-reactive protein (CRP) levels (0.360.06 mg/dL
without and 0.510.10 mg/dL with history of cancer, nonpara-
metric test P0.005) in univariate analysis. However, multivar-
iate analysis did not identify cancer as an independent predictor
of atrial arrhythmias. The finding that cancer was not an
independent predictor of atrial arrhythmias after adjusting for
CRP levels is consistent with inflammation being the causal
intermediary link between cancer and atrial fibrillation.
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